EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Pharmaceutical Injection
Pharmaceutical Injection
Pioneers in the industry, we offer somatropin 4iu (headon injection), testoboob-cp testosterone 250 mg injection, 500mg rituximab injection, cresp 40 mcg darbepoetin alfa injection, darbepoetin alfa injection (cresp 60 mcg injection) and depo testosterone cypionate 200mg injection from India.
Somatropin 4iu (Headon Injection)
Product Price: Rs 825 / VialGet Best Price
Product Brochure
Product Details:
| Brand Name | Headon |
| Strength | 4 I.U |
| Total Strength | 40 IU |
| Brand | Headon |
| Packaging Size | 10*4 IU |
| Composition | Somatropin/recombinant Human Growth Hormone |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Usage | To treat Growth Hormone Deficiency (GHD) |
Overview
Somatropin is a synthetic form of human growth hormone (HGH) used to treat growth disorders in children and hormone deficiency in adults. Headon Injection delivers Somatropin to help promote growth and metabolism.
Indications
- Primary Use: Treatment of growth hormone deficiency in children and adults, including conditions such as Turner syndrome, Prader-Willi syndrome, and chronic kidney disease.
Mechanism of Action
- Somatropin stimulates growth and cell reproduction by mimicking natural growth hormone. It promotes protein synthesis, increases fat breakdown, and helps in the growth of bones and muscles.
Dosage and Administration
- Typical Dosage: The dosage varies based on the condition being treated, usually ranging from 0.1 to 0.3 mg/kg of body weight per week, administered subcutaneously.
- Administration: Inject subcutaneously as directed by a healthcare provider. Rotate injection sites to reduce irritation.
Side Effects
Common Side Effects:
- Injection site reactions (pain, swelling, redness)
- Headaches
- Muscle or joint pain
- Swelling (edema)
Serious Side Effects:
- Allergic reactions (rash, itching, difficulty breathing)
- Increased intracranial pressure (symptoms may include severe headache, nausea, vomiting)
- Diabetes or glucose intolerance
Contraindications
- Hypersensitivity to Somatropin or any component of the injection.
- Active malignancy or serious respiratory illness.
Warnings and Precautions
- Monitor blood glucose levels in patients with a history of diabetes or glucose intolerance.
- Use with caution in patients with a history of intracranial hypertension.
Storage
- Store in the refrigerator (2°C to 8°C). Do not freeze. Protect from light.
Patient Counseling
- Educate patients on proper injection techniques and the importance of adhering to the prescribed dosage schedule.
- Advise monitoring for signs of side effects and to report any unusual symptoms to their healthcare provider.
Conclusion
Somatropin 4 IU (Headon Injection) is a valuable treatment for growth hormone deficiencies and related conditions. Proper administration and monitoring can enhance its effectiveness while minimizing risks. Always consult a healthcare provider for personalized advice and monitoring during treatment.
Yes! I am InterestedRequest A Callback
Testoboob-CP Testosterone 250 mg Injection
Product Price: Rs 225 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg/ml |
| Pack Size | 20 ml |
| Packaging Size | 20 ml |
| Composition | Testosterone |
| Brand Name | Testoboon-CP |
| Manufacturer | Kachhela Medex Pvt Ltd |
| Treatment | Manly Hypogonadism |
Overview
Testoboob-CP is an intramuscular injection containing testosterone, a male sex hormone crucial for the development of male reproductive tissues, as well as promoting secondary sexual characteristics. It is used for testosterone replacement therapy in males with low testosterone levels.
Indications
- Primary Use: Treatment of male hypogonadism (low testosterone levels) due to various causes, including primary or secondary testicular failure.
Mechanism of Action
- Testosterone acts by binding to androgen receptors, leading to various biological effects, including increased muscle mass, bone density, and the development of male sexual characteristics.
Dosage and Administration
- Typical Dosage: The usual dosage for testosterone replacement therapy ranges from 50 mg to 400 mg every 2 to 4 weeks, depending on individual patient needs and response to treatment.
- Administration: Administered as an intramuscular injection, typically into the gluteal muscle.
Side Effects
-
Common Side Effects:
- Acne
- Hair loss
- Weight gain
- Mood changes (e.g., irritability)
-
Serious Side Effects:
- Cardiovascular events (e.g., heart attack, stroke)
- Liver toxicity
- Prostate enlargement or cancer
- Sleep apnea
- Erythrocytosis (increased red blood cell count)
Contraindications
- Hypersensitivity to testosterone or any components of the formulation.
- Men with breast or prostate cancer.
- Severe urinary tract symptoms due to enlarged prostate.
Warnings and Precautions
- Monitor patients for signs of cardiovascular issues, liver function, and changes in mood or behavior.
- Regular blood tests may be necessary to monitor hormone levels and red blood cell counts.
- Use with caution in patients with pre-existing heart conditions or those at risk of developing prostate issues.
Storage
- Store at room temperature (15°C to 30°C) and protect from light. Do not freeze.
Patient Counseling
- Educate patients on the importance of adhering to the prescribed dosage and schedule.
- Discuss potential side effects and encourage reporting of any unusual symptoms.
- Advise on lifestyle modifications that may enhance treatment effectiveness (e.g., exercise, healthy diet).
Conclusion
Testoboob-CP (Testosterone 250 mg injection) is an effective treatment for male hypogonadism. Proper administration, monitoring, and patient education can enhance therapeutic outcomes while minimizing risks. Always consult a healthcare provider for personalized advice and monitoring during treatment.
Yes! I am InterestedRequest A Callback
500mg Rituximab Injection
Product Price: Rs 9,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Dosage Form | Concentrate |
| Brand | Rituxirel |
| Packaging Size | 50 ml |
| Treatment | Blood Cancer (Chronic lymphocytic leukemia) |
| Composition | Rituximab 500 mg |
| Brand Name | RituxiRel |
| Manufactured By | Reliance Life Sciences Pvt Ltd |
Rituximab (500 mg Injection)
OverviewRituximab is a monoclonal antibody used in the treatment of certain types of cancer and autoimmune diseases. It primarily targets the CD20 protein found on the surface of B cells.
Indications- Non-Hodgkin Lymphoma (NHL): Used in various forms of NHL, often in combination with chemotherapy.
- Chronic Lymphocytic Leukemia (CLL): Used in combination with other therapies.
- Rheumatoid Arthritis: In cases where other treatments have not been effective.
- Granulomatosis with Polyangiitis and Microscopic Polyangiitis: For treatment of these autoimmune conditions.
Rituximab binds specifically to CD20 on B cells, leading to their destruction through several mechanisms, including antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). This results in decreased levels of B cells, which are implicated in the disease processes of various cancers and autoimmune disorders.
Dosage and Administration- Typical Dosage: The dosing regimen can vary widely based on the condition being treated, but a common starting dose is 375 mg/m² administered as an intravenous infusion.
- Administration: Infusions are typically given in a healthcare setting to monitor for infusion-related reactions. Subsequent doses may vary depending on the treatment protocol.
- Common Side Effects:
- Infusion-related reactions (fever, chills, nausea)
- Fatigue
- Headache
- Serious Side Effects:
- Severe infections (due to immunosuppression)
- Tumor lysis syndrome (rapid breakdown of tumor cells)
- Cardiac arrhythmias
- Hypersensitivity to rituximab or any component of the formulation.
- Active severe infections.
- Monitor for signs of infusion reactions, especially during the first infusion.
- Screen for infections prior to treatment, as rituximab can increase the risk of infections.
- Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light and do not freeze.
- Inform patients about potential side effects and the importance of reporting any signs of infection.
- Advise them to report any symptoms of infusion reactions during treatment.
Rituximab is an effective treatment for certain cancers and autoimmune disorders. Proper administration and monitoring are essential to ensure safety and efficacy. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Cresp 40 mcg Darbepoetin Alfa Injection
Product Price: Rs 2,500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 40 mcg |
| Brand | Cresp |
| Dose Form | PFS |
| Pack Size | 0.40 ml |
| Composition | Darbepoetin alfa 40 mcg |
| Brand Name | Cresp |
| Manufacturer | Dr Reddy's Laboratories Ltd |
| Treatment | Therapy of Anemia because of constant kidney illness |
Overview: Cresp is an injectable formulation of darbepoetin alfa, a synthetic form of erythropoietin (EPO) that stimulates red blood cell production. It is primarily used in patients with anemia, particularly in chronic kidney disease (CKD) and those undergoing chemotherapy.
Indications- Anemia of Chronic Kidney Disease: Treatment of anemia in patients with CKD, including those on dialysis or not on dialysis.
- Chemotherapy-Induced Anemia: Management of anemia in patients undergoing chemotherapy for certain cancers.
- Surgical Patients: Sometimes used to reduce the need for blood transfusions in patients undergoing major surgery.
Darbepoetin alfa binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating erythropoiesis (red blood cell production) and increasing hemoglobin levels.
Dosage and Administration- Typical Dosage: The initial dose for CKD patients may start at 0.45 mcg/kg once every 4 weeks. For chemotherapy-induced anemia, dosing may start at 2.25 mcg/kg once weekly. Dosage adjustments are based on hemoglobin levels.
- Administration: Given as a subcutaneous or intravenous injection. The route may vary depending on the patient’s condition and treatment setting.
- Common: Headache, nausea, hypertension, and injection site reactions.
- Serious: Risk of thromboembolic events (e.g., stroke, myocardial infarction), particularly if hemoglobin levels rise too quickly.
- Hypersensitivity to darbepoetin alfa or any components of the formulation.
- Uncontrolled hypertension.
- Pure red cell aplasia (PRCA) associated with previous EPO therapy.
- Monitor hemoglobin levels regularly to avoid excessive increases.
- Use cautiously in patients with a history of cardiovascular disease or those at risk for thromboembolic events.
- Store at 2°C to 8°C (refrigerated). Do not freeze. Protect from light. Once removed from refrigeration, it can be stored at room temperature for a limited time.
- Explain the purpose of the medication and how it works.
- Instruct patients on proper injection techniques and the importance of regular blood tests to monitor hemoglobin levels.
- Discuss potential side effects and advise to report any significant changes in health status.
Cresp (Darbepoetin Alfa Injection 40 mcg) is an effective treatment for managing anemia associated with chronic kidney disease and chemotherapy. Proper administration and monitoring are crucial for optimizing treatment outcomes while minimizing risks. Always consult a healthcare provider for personalized treatment plans.
Yes! I am InterestedRequest A Callback
Darbepoetin Alfa Injection (Cresp 60 mcg Injection)
Product Price: Rs 3,850 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 60mcg |
| Brand | Cresp |
| Dose Form | PFS |
| Packaging size | 0.3 ml |
| Packaging Type | 1 Injection in 1 packet |
| Composition | Darbepoetin alfa 60 mcg |
| Brand Name | Cresp |
| Manufacturer | Dr Reddy's Laboratories Ltd |
| Strength / Dose | 60 mcg |
| Treatment | Therapy of Anemia because of constant kidney illness |
Cresp (Darbepoetin Alfa Injection 60 mcg)
Overview: Cresp is an injectable formulation of darbepoetin alfa, a synthetic form of erythropoietin, which is a hormone that stimulates red blood cell production in the bone marrow. It is primarily used to treat anemia associated with chronic kidney disease and certain cancer treatments.
Indications:
- Chronic Kidney Disease: Management of anemia in patients with chronic kidney disease (CKD) not on dialysis.
- Chemotherapy-Induced Anemia: Treatment of anemia in patients with cancer who are undergoing chemotherapy.
Mechanism of Action: Darbepoetin alfa mimics the action of erythropoietin, promoting the formation of red blood cells by binding to erythropoietin receptors in the bone marrow. This increases hemoglobin levels and improves oxygen delivery to tissues.
Dosage and Administration:
- Typical Dosage: The dosage varies based on the indication and the patient's hemoglobin levels. A common starting dose is 0.45 mcg/kg administered once every week or once every two weeks.
- Administration: Given as an intravenous or subcutaneous injection, typically by a healthcare professional.
Side Effects:
- Common: Hypertension, headache, fatigue, and injection site reactions.
- Serious: Increased risk of thromboembolic events (e.g., stroke, heart attack) and serious allergic reactions.
Contraindications:
- Known hypersensitivity to darbepoetin alfa or any components of the formulation.
- Uncontrolled hypertension or a history of pure red cell aplasia.
Warnings and Precautions:
- Monitor hemoglobin levels regularly; avoid rapid increases in hemoglobin.
- Use caution in patients with a history of cardiovascular disease.
Storage:
- Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep in the original carton until use.
Patient Counseling:
- Explain the purpose of the injection and its role in managing anemia.
- Discuss potential side effects, especially the importance of monitoring blood pressure and hemoglobin levels.
Conclusion: Cresp is an effective treatment for anemia in patients with chronic kidney disease and those undergoing chemotherapy. Proper administration and monitoring are essential to ensure safety and optimal outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
Depo Testosterone Cypionate 200mg Injection
Product Price: Rs 2,400 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 200 mg |
| Pack Size | 10 ml |
| Packaging Size | 1 Injection in 1 box |
| Packaging Type | Box |
| Composition | Testosterone Cypionate |
| Form | Injection |
| Brand | Depo |
Depo Testosterone Cypionate 200mg Injection
Overview:
Depo Testosterone Cypionate 200mg injection is a long-acting form of testosterone used to treat low testosterone levels (hypogonadism) in males. It is an androgenic steroid that mimics the naturally occurring testosterone, a hormone responsible for the development and maintenance of male reproductive tissues and secondary sexual characteristics. The medication helps to restore testosterone levels, improve energy, mood, and libido, and support muscle mass and bone density.
Indications:
Depo Testosterone Cypionate 200mg Injection is indicated for:
- Hypogonadism: To treat low testosterone in men, which may cause symptoms like fatigue, depression, and reduced libido.
- Delayed Puberty: In males who experience delayed onset of puberty.
- Hormonal Replacement Therapy: For men who do not produce enough testosterone naturally.
Mechanism of Action:
Testosterone cypionate is a synthetic form of testosterone. It is injected into the muscle, where it is absorbed slowly into the bloodstream. Once in circulation, testosterone acts on various tissues to regulate functions like muscle growth, bone density, sexual function, and red blood cell production. By increasing testosterone levels, Depo Testosterone Cypionate helps reverse symptoms of low testosterone and improves overall well-being.
Dosage and Administration:
- Recommended Dose: The typical starting dose is 200–400 mg every 2–4 weeks, depending on individual needs and response. The dosage may be adjusted based on blood testosterone levels.
- Administration: Depo Testosterone Cypionate is administered intramuscularly by a healthcare provider, typically in the gluteal muscle.
- Missed Dose: If a dose is missed, it should be given as soon as possible, unless it's near the next scheduled dose.
Side Effects:
Common side effects include:
- Injection site pain, acne, mood swings, and increased body hair.
Serious side effects may include: - Cardiovascular issues: High blood pressure and increased risk of heart disease.
- Liver problems: Elevated liver enzymes or jaundice.
- Sleep apnea: Worsening of obstructive sleep apnea in some patients.
Precautions:
- Prostate Cancer: Should not be used in men with prostate cancer or a history of prostate cancer.
- Heart Disease: Use with caution in men with cardiovascular disease.
- Pregnancy and Breastfeeding: Contraindicated in females, as testosterone may cause harm to the fetus.
Storage:
Store Depo Testosterone Cypionate 200mg Injection at room temperature (20°C to 25°C), away from light and moisture. Keep out of reach of children.
Conclusion:
Depo Testosterone Cypionate 200mg Injection is an effective treatment for low testosterone levels and related symptoms. Monitoring for side effects, especially cardiovascular and liver-related issues, is essential during treatment.
Yes! I am InterestedRequest A Callback
Fludot Flumazenil 0.5mg Injection
Product Price: Rs 800 / PieceGet Best Price
Product Brochure
Product Details:
| Packaging Size | 5 ml |
| Strength | 0.5 mg/ 5ml |
| Composition | Flumazenil 0.5 mg/5 ml |
| Brand Name | Fludot |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Benzodiazepine Overdose |
Overview
Fludot is an injectable formulation of Flumazenil, a benzodiazepine antagonist used primarily to reverse the effects of benzodiazepine sedation and to treat benzodiazepine overdose.
Primary Use:
- Reversal of sedation caused by benzodiazepines during medical procedures.
- Treatment of benzodiazepine overdose to restore consciousness and normal respiratory function.
Flumazenil functions as a competitive antagonist at the GABA-A receptor, effectively blocking the sedative effects of benzodiazepines and helping to restore normal physiological function.
Dosage and AdministrationTypical Dosage:
- For reversal of sedation: Initial dose of 0.2 mg (2 mL) IV, may repeat with additional doses of 0.3 mg at 60-second intervals as needed, up to a maximum of 3 mg.
Administration:
- Administer via slow intravenous infusion by a qualified healthcare professional, with continuous monitoring of the patient.
Common Side Effects:
- Dizziness
- Nausea
- Agitation
- Headache
Serious Side Effects:
- Seizures (especially in patients with a history of seizures or prolonged benzodiazepine use)
- Allergic reactions (e.g., rash, difficulty breathing)
- Hypersensitivity to Flumazenil or any components of the formulation.
- Patients with a history of seizures or those who are dependent on benzodiazepines.
- Monitor for potential resedation, particularly if the effects of the benzodiazepine last longer than Flumazenil.
- Caution is advised in patients with a history of substance abuse or dependence.
- Store at room temperature (15°C to 30°C), protected from light.
- Educate patients about the purpose of the medication and the importance of adhering to the prescribed regimen.
- Advise them to report any side effects, particularly signs of allergic reactions or seizures.
Fludot (Flumazenil 0.5 mg injection) is a critical treatment for managing benzodiazepine overdose and reversing sedation. Proper administration and monitoring are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and management during treatment.
Yes! I am InterestedRequest A Callback
2mg Bortezomib Injection (Bortezest)
Product Price: Rs 4,450 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Dose/Strength | 2 mg |
| Packaging Size | 2 mg Vial |
| Composition | Bortezomib 2 mg |
| Brand Name | Bortezest |
| Manufacturer | Onco Zest |
| Treatment | Multiple Myeloma |
Bortezomib Injection (2 mg)
OverviewBortezomib is a proteasome inhibitor used primarily in the treatment of certain hematologic cancers, including multiple myeloma and certain types of lymphoma. It interferes with the cell's ability to degrade proteins, leading to an accumulation of regulatory proteins that promote apoptosis (cell death) in cancer cells.
Indications- Multiple Myeloma: Used for the treatment of patients who have received at least one prior therapy.
- Mantle Cell Lymphoma: Indicated for patients who have received at least one prior therapy.
Bortezomib inhibits the proteasome, a cellular complex responsible for degrading unneeded or damaged proteins. By disrupting this process, bortezomib leads to an accumulation of pro-apoptotic factors and a decrease in anti-apoptotic proteins, promoting cancer cell death.
Dosage and Administration- Typical Dosage: The usual dose is 1.3 mg/m² body surface area, administered as an injection either subcutaneously or intravenously. The specific regimen may vary based on the treatment protocol and the patient's condition.
- Administration: Administered by a healthcare professional. For subcutaneous injections, the injection should be given into the abdomen or thigh.
- Common Side Effects:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Peripheral neuropathy (tingling, numbness)
- Thrombocytopenia (low platelet count)
- Serious Side Effects:
- Severe infections
- Heart problems (e.g., heart failure)
- Gastrointestinal perforation (rare)
- Hypersensitivity to bortezomib or any component of the formulation.
- Caution in patients with a history of herpes zoster infection.
- Monitor blood counts regularly due to the risk of myelosuppression.
- Patients should be monitored for signs of infection and peripheral neuropathy.
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Do not freeze.
- Advise patients to report any signs of infection, unusual bleeding or bruising, and symptoms of peripheral neuropathy.
- Discuss potential side effects and the importance of regular follow-up appointments for monitoring.
Bortezomib is a critical treatment option for multiple myeloma and certain lymphomas, effectively targeting cancer cell survival pathways. Proper administration and monitoring are essential for maximizing the benefits and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
22.5 MG Leuprorelin Acetate Injection(LEUGARD DEPOT)
Product Price: Rs 7,500 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 22.5 mg |
| Packaging Type | Vial |
| Treatment | Prostate Cancer |
| Composition | Leuprorelin Acetate |
| Manufacturer | Zydus Cadila |
| Brand | Leugard |
22.5mg Leuprorelin Acetate Injection (LEUGARD DEPOT)
Overview:
Leuprorelin Acetate (marketed as LEUGARD DEPOT) is a synthetic gonadotropin-releasing hormone (GnRH) agonist used in the treatment of various hormone-dependent conditions, primarily prostate cancer, endometriosis, and uterine fibroids. It works by reducing the secretion of testosterone in men and estrogen in women, effectively lowering the levels of these hormones in the body. By suppressing hormone production, Leuprorelin helps shrink tumors or reduce symptoms related to estrogen or testosterone excess.
Indications:
LEUGARD DEPOT (Leuprorelin Acetate 22.5mg) is primarily used for:
- Prostate Cancer: For androgen deprivation therapy (ADT) in advanced prostate cancer.
- Endometriosis: To manage symptoms by reducing estrogen levels, which help control endometriosis-related pain.
- Uterine Fibroids: To reduce the size of fibroids and control associated symptoms like heavy bleeding.
Mechanism of Action:
Leuprorelin is a GnRH agonist that initially stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). After a few weeks of continuous administration, it causes a significant decrease in the secretion of testosterone (in men) and estrogen (in women) due to a negative feedback loop. This suppression of gonadal hormones results in a state similar to chemical castration, helping to control the growth of hormone-dependent cancers and conditions.
Dosage and Administration:
- Recommended Dose: The typical dose for prostate cancer is 22.5mg administered every 3 months via subcutaneous injection.
- Administration: LEUGARD DEPOT is administered as a single subcutaneous injection by a healthcare professional.
- Missed Dose: If a dose is missed, it should be administered as soon as possible, but the injection schedule should remain on track.
Side Effects:
Common side effects include:
- Hot flashes, erectile dysfunction, decreased libido, fatigue, and sweating.
Serious side effects may include: - Bone loss: Prolonged use can lead to decreased bone mineral density.
- Cardiovascular issues: Increased risk of heart-related problems.
- Injection site reactions: Pain, swelling, or redness at the injection site.
Precautions:
- Bone Health: Monitor for signs of bone density loss, especially during long-term therapy.
- Cardiovascular Disease: Use with caution in patients with heart conditions.
- Pregnancy: LEUGARD DEPOT is contraindicated in pregnancy and should be used with caution in women of childbearing potential.
Storage:
Store LEUGARD DEPOT (Leuprorelin Acetate) at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
LEUGARD DEPOT (Leuprorelin Acetate 22.5mg) is an effective treatment for hormone-dependent cancers and conditions. By reducing testosterone and estrogen levels, it helps manage symptoms and control disease progression. Regular monitoring for side effects, particularly related to bone health and cardiovascular risks, is essential during treatment.
Yes! I am InterestedRequest A Callback
Fenbendazole 222 Mg Tablet
Product Price: Rs 110 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 222 mg |
| Pack Size | 10 Tablets |
| Animal Type | Human Grade |
| Packaging Size | 1X10 Tablets |
| Dose/Strength | 222mg |
| Packaging Type | Stripe |
| Country of Origin | Made in India |
| Brand Name | Kachhela |
Fenbendazole is a broad-spectrum benzimidazole anthelmintic used mainly in veterinary medicine. It kills parasitic worms and certain protozoa by interfering with their energy metabolism. Known for its safety and reliability, it helps control intestinal parasites in animals. Though studied for possible anticancer effects, human use remains investigational and unapproved.
IndicationsFenbendazole 222 mg tablets are indicated for the treatment and control of gastrointestinal parasites in animals, including:
-
Roundworms (Toxocara, Toxascaris)
-
Hookworms (Ancylostoma, Uncinaria)
-
Whipworms (Trichuris species)
-
Tapeworms (Taenia species)
-
Giardia spp. (intestinal protozoa)
Any human or off-label use should occur only under proper medical supervision.
Mechanism of ActionFenbendazole binds to β-tubulin in parasite cells, preventing microtubule formation. This blocks glucose uptake and depletes energy stores, leading to parasite death. The same process has drawn research interest in oncology, but this use is still experimental.
Dosage and AdministrationFormulation: Oral tablet containing 222 mg fenbendazole.
Typical Veterinary Dose: 5 mg/kg body weight once daily for three consecutive days, adjusted by species and infection type.
Give with food to improve absorption. A repeat course may be prescribed if needed.
Note: Human dosing protocols are not approved for clinical use.
Side EffectsCommon:
-
Mild nausea or stomach upset
-
Diarrhea or temporary appetite loss
-
Fatigue or dizziness
Rare:
-
Allergic reactions (rash, swelling)
-
Reversible liver enzyme elevation
-
Blood changes with long-term use
Most side effects are mild and self-limiting.
Monitoring-
Stool testing to confirm parasite clearance
-
Liver function checks during extended use
-
Observation for allergic or digestive issues
Avoid use in:
-
Animals or individuals allergic to benzimidazoles
-
Pregnant animals unless advised by a veterinarian
-
Humans outside approved research settings
Few significant interactions are known. Use caution with drugs affecting liver enzymes or microtubule activity. Inform the veterinarian or healthcare provider of any other medications or supplements being taken.
Storage Instructions-
Store at 20°C–25°C (68°F–77°F).
-
Keep sealed, dry, and away from light.
-
Do not freeze or use after expiry.
-
Keep out of reach of children and animals.
-
Explain treatment purpose and correct dosing.
-
Administer with food and complete the full course.
-
Report unusual reactions or persistent symptoms.
-
Emphasize that fenbendazole is a veterinary product, not approved for regular human use.
Fenbendazole 222 mg tablets are effective antiparasitic agents that target a wide range of intestinal worms and protozoa in animals. By disrupting parasite metabolism, they ensure reliable control and better gastrointestinal health. Although ongoing studies explore new possibilities, its recognized and approved role remains as a safe, dependable veterinary anthelmintic. Always use under professional direction.
Yes! I am InterestedRequest A Callback
Fenbendazole 444mg Tablets
Product Price: Rs 175 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 444 mg |
| Animal Type | Human Grade |
| Pack Size | Strip |
| Composition | Fenbendazole 444mg |
| Packaging Type | Strip |
| Grade Standard | USP |
| Country of Origin | Made in India |
| Dose/Strength | 444 mg |
Fenbendazole is a broad-spectrum benzimidazole anthelmintic widely used in veterinary medicine. It destroys intestinal worms and certain protozoa by disrupting their energy metabolism. The 444 mg strength allows convenient dosing for larger animals. Fenbendazole is recognized for its strong safety record and efficacy. Although studied for possible anticancer activity, human use remains experimental and unapproved.
IndicationsFenbendazole 444 mg tablets are indicated for the treatment and control of intestinal parasites in animals, including:
-
Roundworms (Toxocara, Toxascaris)
-
Hookworms (Ancylostoma, Uncinaria)
-
Whipworms (Trichuris species)
-
Tapeworms (Taenia species)
-
Giardia spp. (intestinal protozoa)
Use only under veterinary guidance. Any human or off-label use requires medical supervision.
Mechanism of ActionFenbendazole binds to β-tubulin in parasite cells, preventing microtubule formation. This blocks glucose uptake, depleting the parasite’s energy and leading to its death. The same mechanism has drawn scientific interest in cancer research, though such use is investigational.
Dosage and AdministrationFormulation: Oral tablet containing 444 mg fenbendazole.
Veterinary Dose: Typically 5 mg/kg body weight once daily for three days, adjusted for species and infection type.
Administer with food to enhance absorption. Repeat treatment if recommended by a veterinarian.
Note: Dosing for humans is not medically approved.
Side EffectsCommon:
-
Mild nausea or stomach upset
-
Temporary appetite loss or diarrhea
-
Fatigue or mild dizziness
Rare:
-
Allergic skin reactions
-
Elevated liver enzymes (reversible)
-
Blood changes with prolonged use
Most effects are mild and resolve after treatment.
Monitoring-
Stool checks to confirm parasite clearance
-
Liver function monitoring in extended therapy
-
Watch for allergic or digestive reactions
Avoid use in:
-
Animals or individuals allergic to benzimidazoles
-
Pregnant animals unless advised by a veterinarian
-
Humans outside approved clinical trials
Few known interactions. Use caution with drugs affecting liver metabolism or microtubule function. Always inform your veterinarian or healthcare provider of any other medications or supplements.
Storage Instructions-
Store at 20°C–25°C (68°F–77°F) in a dry, dark place.
-
Keep container tightly closed.
-
Do not freeze or use after expiry.
-
Keep out of reach of children and animals.
-
Explain the purpose and correct dosing.
-
Give with food and complete the prescribed course.
-
Report unusual symptoms such as vomiting, rash, or weakness.
-
Remember: fenbendazole is a veterinary product and not approved for routine human use.
Fenbendazole 444 mg tablets are effective and well-tolerated antiparasitic agents for controlling a wide range of worms and protozoa in animals. By inhibiting parasite metabolism, they ensure reliable parasite clearance and improved gastrointestinal health. While ongoing studies explore potential new uses, fenbendazole’s approved and proven role remains in veterinary parasite management.
Yes! I am InterestedRequest A Callback
Piperacillin Tazobactam 2.25 mg Injection (pipzo 2.25 mg Injection)
Product Price: Rs 145 / VialGet Best Price
Product Brochure
Product Details:
| Piperacillin strength | 2.25 g |
| Strength | 2.25 g |
| Tazobactam strength | 250 mg |
| Pack size | 1 vial |
| Dose/Strength | 2.25 g |
| Composition | Piperacillin (2 gm) + Tazobactum (250 mg) |
| Brand Name | Pipzo |
| Manufactured By | Alkem Laboratories Ltd |
| Treatment | Bacterial Diseases |
Pipzo (Piperacillin/Tazobactam Injection 2.25 g)
Overview: Pipzo is an injectable combination of piperacillin, a broad-spectrum penicillin antibiotic, and tazobactam, a beta-lactamase inhibitor. This combination enhances the efficacy of piperacillin against certain resistant bacteria.
Indications:
- Intra-abdominal Infections: Treatment of complicated intra-abdominal infections.
- Skin and Soft Tissue Infections: Effective for treating moderate to severe skin infections.
- Pneumonia: Management of community-acquired pneumonia or hospital-acquired pneumonia.
- Sepsis: Used in severe infections and sepsis caused by susceptible organisms.
Mechanism of Action: Piperacillin works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Tazobactam protects piperacillin from degradation by beta-lactamase enzymes produced by certain bacteria, enhancing its antibacterial activity.
Dosage and Administration:
- Typical Dosage: The standard dosage is usually 3.375 g (2.25 g piperacillin and 0.375 g tazobactam) every 6 to 8 hours, depending on the severity of the infection and patient factors.
- Administration: Administered via intravenous infusion or injection, typically by a healthcare professional.
Side Effects:
- Common: Diarrhea, nausea, rash, and changes in liver enzyme levels.
- Serious: Allergic reactions, Clostridium difficile-associated diarrhea, and renal impairment.
Contraindications:
- Known hypersensitivity to piperacillin, tazobactam, or other penicillin antibiotics.
- Caution in patients with a history of severe allergies or asthma.
Warnings and Precautions:
- Monitor for signs of anaphylaxis during the first dose.
- Regularly check kidney function and liver enzymes during treatment.
Storage:
- Store at room temperature, away from light. Follow specific manufacturer guidelines for reconstitution and storage.
Patient Counseling:
- Explain the purpose of the injection and its role in treating infections.
- Discuss potential side effects, particularly the importance of reporting severe gastrointestinal symptoms.
Conclusion: Pipzo is an effective treatment option for a variety of bacterial infections, especially those caused by resistant organisms. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
2mg Bortezomib Injection
Product Price: Rs 9,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 2 mg |
| Dose/Strength | 2 mg |
| Brand | Bortrlive |
| Pack Size | Vial |
| Composition | Bortezomib 2 mg |
| Manufacturer | Admac Lifesciences (Oncology) |
| Treatment | Multiple Myeloma & Mantle Cell Lymphoma. |
| Pack Type | 1 Injection in 1 vial |
| Brand Name | Bortrlive |
2mg Bortezomib Injection
Overview:
Bortezomib is a proteasome inhibitor used in the treatment of various cancer types, primarily multiple myeloma and mantle cell lymphoma. By inhibiting the proteasome, Bortezomib interferes with the breakdown of proteins within cells, leading to the accumulation of damaged proteins and ultimately inducing cell death, particularly in cancer cells that rely on this protein degradation for survival.
Indications:
2mg Bortezomib Injection is primarily indicated for:
- Multiple Myeloma: Used in combination with other drugs for the treatment of newly diagnosed and relapsed multiple myeloma.
- Mantle Cell Lymphoma: For the treatment of patients with relapsed or refractory mantle cell lymphoma who have received at least one prior therapy.
Mechanism of Action:
Bortezomib specifically inhibits the proteasome, a complex responsible for degrading unneeded or damaged proteins. In cancer cells, inhibiting this process causes a buildup of toxic proteins, disrupting vital cellular functions and leading to apoptosis (cell death). This effect is particularly potent in rapidly dividing cancer cells, such as those found in multiple myeloma and mantle cell lymphoma.
Dosage and Administration:
- Recommended Dose: The usual dose is 1.3 mg/m² of body surface area, administered via intravenous injection or subcutaneous injection.
- Schedule: Typically, Bortezomib is given on days 1, 4, 8, and 11 of a 21-day cycle for the first two cycles, followed by once-weekly dosing for subsequent cycles.
- Administration: The injection is administered slowly over 3 to 5 seconds (IV), or it can be given as a subcutaneous injection. The dosage schedule may vary based on the patient's response and tolerability.
Side Effects:
Common side effects include:
- Nausea, diarrhea, fatigue, peripheral neuropathy (numbness, tingling, or pain in the hands and feet), and low blood cell counts. Serious side effects include:
- Cardiotoxicity: Risk of heart problems, including heart failure.
- Hepatotoxicity: Liver function should be monitored.
- Severe infections: Due to immune system suppression.
Precautions:
- Peripheral Neuropathy: Dose adjustments may be required if the patient experiences severe neuropathy.
- Infection Risk: Patients should be monitored for signs of infections, as Bortezomib can lower immune function.
- Pregnancy and Breastfeeding: Bortezomib is contraindicated in pregnancy and should not be used during breastfeeding.
Storage:
Store 2mg Bortezomib Injection at room temperature (20°C to 25°C). Avoid light and protect from freezing.
Conclusion:
2mg Bortezomib Injection is an effective treatment for multiple myeloma and mantle cell lymphoma. It works by inhibiting protein degradation in cancer cells, inducing cell death and halting tumor growth. Regular monitoring for side effects like neuropathy, liver function, and blood counts is important for patient safety.
Yes! I am InterestedRequest A Callback
Clofarabine Farabine 20 mg Injection
Product Price: Rs 9,000 / VialGet Best Price
Product Brochure
Product Details:
| Treatment Type | Blood Cancer |
| Dosage Form | Injection |
| Brand | Farabine |
| Composition | Clofarabine |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Strength | 20 mg/ml |
| Packaging Size | 1 Vial |
| Treatment | Blood Cancer |
Farabine (Clofarabine) 20 mg Injection
OverviewFarabine contains clofarabine, a chemotherapy medication used primarily in the treatment of acute lymphoblastic leukemia (ALL) in pediatric patients. It is classified as a nucleoside analog, which interferes with DNA synthesis and replication.
Indications- Acute Lymphoblastic Leukemia (ALL): Approved for the treatment of relapsed or refractory ALL in children and young adults.
Clofarabine works by inhibiting DNA synthesis and repair. It gets incorporated into DNA and disrupts its function, ultimately leading to cell death. By targeting rapidly dividing cancer cells, clofarabine helps to reduce tumor burden.
Dosage and Administration- Typical Dosage: The recommended dosage for children is generally 52 mg/m² administered as an intravenous infusion over 2 hours for 5 consecutive days. Treatment cycles may vary based on patient response and recovery from previous treatments.
- Administration: Clofarabine should be given by a healthcare professional, typically in a clinical setting equipped to manage chemotherapy.
- Common Side Effects:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Fever
- Mucositis (inflammation of mucous membranes)
- Serious Side Effects:
- Myelosuppression (decreased blood cell counts)
- Infections due to immunosuppression
- Hepatotoxicity (liver damage)
- Hypersensitivity to clofarabine or any of its components.
- Use is contraindicated in patients with severe renal impairment.
- Monitor blood counts regularly due to the risk of myelosuppression.
- Assess liver function before and during treatment.
- Be vigilant for signs of infection, as immunosuppression can increase susceptibility.
- Store at room temperature (20°C to 25°C / 68°F to 77°F) away from light. Follow specific handling and disposal instructions, as it is a cytotoxic agent.
- Educate patients and caregivers about potential side effects and the importance of reporting symptoms promptly.
- Discuss the need for regular blood tests and follow-up appointments during treatment.
- Advise on the importance of hydration and nutritional support during therapy.
Farabine (clofarabine) 20 mg injection is a vital treatment option for acute lymphoblastic leukemia in children and young adults. Proper administration, monitoring for side effects, and patient education are essential for effective treatment outcomes. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Succinyl Choline Chloride (Sucol Injection)
Product Price: Rs 40 / VialGet Best Price
Product Brochure
Product Details:
| Brand | Sucol |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Skeletal muscle relaxation during surgery or other medical procedures |
| Dose / Strength | 50 mg |
| Packaging Type | 1 Vial 10 ml Injection |
| Composition | Succinylcholine Chloride (50mg) |
Sucol (Succinyl Choline Chloride Injection)
Overview: Sucol is an injectable formulation of succinylcholine chloride, a neuromuscular blocking agent used to induce temporary paralysis during surgical procedures or intubation.
Indications:
- Surgical Procedures: Facilitates intubation and provides muscle relaxation during surgery.
- Emergency Medicine: Used in rapid sequence intubation to achieve quick paralysis.
Mechanism of Action: Succinylcholine works by binding to nicotinic acetylcholine receptors at the neuromuscular junction, causing initial muscle fasciculations followed by prolonged muscle relaxation due to its depolarizing action. It prevents muscle contraction by blocking the transmission of nerve impulses.
Dosage and Administration:
- Typical Dosage: Dosing varies based on the procedure and patient factors, but a common dose for adults is 0.5 to 1 mg/kg administered intravenously.
- Administration: Given by a healthcare professional, often in a clinical or surgical setting.
Side Effects:
- Common: Muscle fasciculations, postoperative muscle pain, and elevated serum potassium levels.
- Serious: Risk of malignant hyperthermia, cardiac arrhythmias, or allergic reactions.
Contraindications:
- Known hypersensitivity to succinylcholine.
- Conditions such as malignant hyperthermia or a personal/family history of it.
Warnings and Precautions:
- Monitor for signs of respiratory distress or cardiovascular complications.
- Use caution in patients with a history of neuromuscular disorders, burns, or severe trauma.
Storage:
- Store at room temperature, protected from light. Follow specific storage instructions from the manufacturer.
Patient Counseling:
- Explain the purpose of the injection and its use in facilitating surgery or intubation.
- Discuss potential side effects and the importance of monitoring during and after administration.
Conclusion: Sucol is a valuable neuromuscular blocker used in various medical settings. Proper administration and monitoring are crucial for safety and effectiveness. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
Methylprednisolone Injection (Neo- Drol 500 mg Injection)
Product Price: Rs 400 / VialGet Best Price
Product Brochure
Product Details:
| Salt Form | Sodium succinate |
| Strength | 500mg |
| Pack Size | Box of 1 vial |
| Packaging Size | 1ml |
| Composition | Methylprednisolone (500 mg) |
| Brand Name | Neo-Drol |
| Manufactured By | Neon Laboratories Ltd |
| Treatment | Rheumatic Disorder |
Neo-Drol (Methylprednisolone Injection 500 mg)
Overview: Neo-Drol is an injectable formulation of methylprednisolone, a corticosteroid used to reduce inflammation and suppress the immune response. It is utilized in a variety of medical conditions, particularly those involving inflammation and autoimmune responses.
Indications:
- Inflammatory Conditions: Treatment of severe allergic reactions, asthma exacerbations, and conditions like rheumatoid arthritis and lupus.
- Autoimmune Diseases: Management of autoimmune disorders, such as multiple sclerosis.
- Organ Transplant: Used to prevent organ rejection.
- Other Conditions: Can also be indicated for certain skin disorders, gastrointestinal diseases, and some forms of cancer.
Mechanism of Action: Methylprednisolone works by modulating the immune response and decreasing inflammation through inhibition of inflammatory mediators and immune cell function.
Dosage and Administration:
- Typical Dosage: The dosage varies based on the condition being treated, but common doses can range from 40 mg to 1,200 mg per day, depending on the severity and type of the condition.
- Administration: Given as an intravenous or intramuscular injection by a healthcare professional.
Side Effects:
- Common: Fluid retention, increased appetite, mood changes, and insomnia.
- Serious: Increased risk of infections, gastrointestinal bleeding, and adrenal suppression.
Contraindications:
- Known hypersensitivity to methylprednisolone or any formulation components.
- Systemic fungal infections and certain viral infections (e.g., varicella).
Warnings and Precautions:
- Monitor for signs of infection or adrenal insufficiency.
- Use with caution in patients with a history of hypertension, diabetes, or peptic ulcers.
Storage:
- Store at room temperature, away from light. Follow specific manufacturer instructions for storage.
Patient Counseling:
- Explain the purpose of the injection and its potential benefits in reducing inflammation and managing symptoms.
- Discuss possible side effects, especially the importance of reporting signs of infection or unusual symptoms.
Conclusion: Neo-Drol is an effective treatment for various inflammatory and autoimmune conditions. Proper administration and monitoring are crucial to ensure safety and effectiveness. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
Contrapaque Iohexol 350mg Injection
Product Price: Rs 789 / VialGet Best Price
Product Brochure
Product Details:
| Brand | Contrapaque |
| Dose | 350 mg/ml |
| Strength | 350 mgI/mL |
| Volume | 100 mL |
| Packaging Size | 100ml |
| Usage/Application | Hospital |
| Composition | Lohexol |
| Shelf Life | 24 Month |
| Country of Origin | Made in India |
Contrapaque (Iohexol) 350 mg Injection
Indications: Contrapaque (Iohexol) is primarily indicated for:
- Radiographic Imaging: As a contrast agent in various imaging studies, including:
- Computed Tomography (CT) scans
- Angiography
- Myelography
- Intravenous urography
Mechanism of Action: Iohexol is a non-ionic, water-soluble contrast agent that works by:
- Increasing the radiopacity of tissues and blood vessels, allowing for enhanced visualization during imaging procedures. It absorbs X-rays, making structures more distinguishable on radiographic images.
Dosage and Administration:
- Dosage: The dosage varies based on the specific imaging procedure and patient factors. Commonly, it ranges from 50 to 150 mL for adults, depending on the examination type.
- Administration: Administered via intravenous injection or infusion, or directly into the body cavity depending on the imaging study. It should be given by healthcare professionals trained in radiologic procedures.
Contraindications:
- Hypersensitivity to iohexol or any component of the formulation.
- History of severe allergic reactions to iodinated contrast agents.
- Caution in patients with severe renal impairment or dehydration.
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of an allergic reaction, ranging from mild (rash, itching) to severe (anaphylaxis).
- Renal Function: Assess renal function before administration, particularly in at-risk populations (e.g., elderly patients, those with pre-existing kidney disease).
- Thyroid Function: Use with caution in patients with thyroid disease, as iodinated contrast agents can affect thyroid function.
Side Effects:
- Common: Nausea, vomiting, warm sensation, headache, and transient hypotension.
- Serious: Severe allergic reactions, nephrotoxicity, and thyroid dysfunction.
Drug Interactions: Iohexol may interact with other medications affecting renal function or causing allergic reactions. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the purpose of the contrast agent and the potential for side effects.
- Advise patients to report any allergic reactions or unusual symptoms after administration.
Conclusion: Contrapaque (Iohexol) 350 mg Injection is an essential contrast agent for enhancing imaging studies. Careful administration and monitoring for side effects are crucial for patient safety and effective imaging outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Amphonat 50mg injection
Product Price: Rs 4,683 / VialGet Best Price
Product Brochure
Product Details:
| Formulation Type | Liposomal |
| Dosage/Strength | 50 mg |
| Strength | 50 mg vial |
| Brand | Amphonat |
| Composition | Liposomal Amphotericin B 50mg |
| Form | Injection |
| Manufacturer | NATCO |
| Prescription/Non prescription | Non prescription |
| Treatment | Severe Fungal Infections |
Amphonat 50 mg Injection
Overview: Amphonat is an injectable formulation of amphotericin B, an antifungal medication primarily used to treat serious fungal infections.
Indications:
- Systemic Fungal Infections: Effective for treating invasive infections caused by fungi such as Aspergillus, Candida, and Cryptococcus.
- Severe Mycoses: Used in patients who are immunocompromised or have serious underlying health conditions.
Mechanism of Action: Amphotericin B binds to ergosterol, a key component of fungal cell membranes, leading to membrane disruption and cell death.
Dosage and Administration:
- Dosage: The typical dosage can vary based on the specific infection being treated and patient factors, but a common range is 0.5 to 1 mg/kg body weight per day.
- Administration: Administered intravenously; infusions should be done slowly to minimize infusion-related reactions.
Contraindications:
- Hypersensitivity to amphotericin B or any component of the formulation.
- Caution in patients with renal impairment, as the drug can be nephrotoxic.
Warnings and Precautions:
- Monitor renal function and electrolytes regularly, as amphotericin B can cause renal toxicity and electrolyte imbalances.
- Be vigilant for signs of infusion reactions, such as fever, chills, and hypotension.
Side Effects:
- Common: Fever, chills, nausea, vomiting, headache, and infusion site reactions.
- Serious: Risk of nephrotoxicity, hypokalemia, and severe allergic reactions.
Drug Interactions: Caution is advised when used with other nephrotoxic agents or medications that may affect renal function.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and possible side effects.
- Advise them to report any unusual symptoms, especially those related to kidney function or severe allergic reactions.
Conclusion: Amphonat 50 mg injection is an important treatment option for serious fungal infections. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Levetiracetam (Epicetam 500 mg Injection)
Product Price: Rs 800 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Vial Volume | 5 ml |
| Release Type | Immediate |
| Formulation | Immediate |
| Pack Size | Vial |
| Pack Type | 5 ml in 1 vial |
| Composition | Levetiracetam 500 mg |
| Brand Name | Epicetam |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Epilepsy/Seizures |
Overview: Epicetam is an injectable formulation of levetiracetam, an anticonvulsant medication used primarily for the treatment of seizures in various types of epilepsy.
Indications- Partial-Onset Seizures: Treatment of partial-onset seizures in adults and children with epilepsy.
- Myoclonic Seizures: Effective for myoclonic seizures in patients with juvenile myoclonic epilepsy.
- Generalized Tonic-Clonic Seizures: Used as part of the treatment regimen for generalized tonic-clonic seizures.
Levetiracetam works by modulating the release of neurotransmitters and inhibiting excitatory synaptic transmission. Its precise mechanism is not fully understood, but it is thought to involve binding to the synaptic vesicle protein SV2A, which is important for neurotransmitter release.
Dosage and Administration- Typical Dosage: The initial dose may vary based on the type of seizures being treated. For adults, it is often started at 500 mg administered intravenously, with potential adjustments based on clinical response.
- Administration: Given as an intravenous infusion. The injection can also be used in patients who are unable to take oral medication.
- Common: Drowsiness, fatigue, dizziness, and headache.
- Serious: Behavioral changes, mood swings, or suicidal thoughts. Monitor for signs of hypersensitivity or allergic reactions.
- Hypersensitivity to levetiracetam or any of its components.
- Caution in patients with a history of depression or mood disorders.
- Monitor for changes in behavior or mood, especially during treatment initiation and dose adjustments.
- Consider renal function; dose adjustments may be necessary in patients with renal impairment.
- Store at room temperature, protected from light. Follow specific storage guidelines provided by the manufacturer.
- Educate patients about the purpose of the medication and the importance of adhering to prescribed dosages.
- Discuss potential side effects and advise them to report any significant changes in mood or behavior.
Epicetam (Levetiracetam 500 mg injection) is an effective treatment option for managing various seizure types in patients with epilepsy. Proper administration and monitoring are essential to ensure optimal therapeutic outcomes while minimizing risks. Always consult a healthcare provider for tailored treatment recommendations.
Yes! I am InterestedRequest A Callback
Citicoline Injection (Strocit 2 ml Injection )
Product Price: Rs 135 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 250mg |
| Combination | With Piracetam |
| Usage | Head Injury, Stroke |
| Strength / Dose | 250 mg |
| Packaging Type | 2 ml in 1 ampoule |
| Composition | Citicoline (250 mg/ml) |
| Brand Name | Strocit |
| Manufactured By | Sun Pharmaceutical Industries Ltd |
| Treatment | Head Injuries |
Overview: Strocit is an injectable formulation of citicoline, a neuroprotective agent that supports brain health and function. It is used in various neurological conditions and to enhance cognitive recovery.
Indications- Acute Ischemic Stroke: Used as part of the treatment protocol to support recovery after an ischemic stroke.
- Cognitive Disorders: Helps in managing cognitive impairment associated with conditions such as Alzheimer's disease or other types of dementia.
- Traumatic Brain Injury: Supports recovery and brain function following traumatic brain injuries.
Citicoline acts as a precursor to phospholipids in cell membranes, particularly phosphatidylcholine. It enhances membrane integrity, promotes neuronal repair, and supports neurotransmitter synthesis, contributing to improved brain function and neuroprotection.
Dosage and Administration- Typical Dosage: Commonly, a dose of 500 mg to 1,000 mg (2 ml) is administered once daily, but the exact dosage may vary based on the clinical situation.
- Administration: Given as an intravenous or intramuscular injection, typically in a healthcare setting.
- Common: Headache, gastrointestinal upset (nausea, diarrhea), and injection site reactions.
- Serious: Rarely, allergic reactions or changes in blood pressure may occur.
- Hypersensitivity to citicoline or any components of the formulation.
- Caution in patients with a history of cardiovascular issues.
- Monitor patients for any adverse reactions during and after administration.
- Use cautiously in individuals with severe renal or hepatic impairment.
- Store at room temperature, away from light. Protect from freezing. Follow specific storage instructions provided by the manufacturer.
- Explain the purpose of the injection and its potential benefits for brain health.
- Discuss possible side effects and encourage patients to report any unusual symptoms.
Strocit (Citicoline Injection 2 ml) is a valuable treatment option for supporting brain health in various neurological conditions. Proper administration and monitoring are essential for achieving optimal therapeutic outcomes while minimizing risks. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
Mecobalamin Folic Acid Niacamide (Nurostar C)
Product Price: Rs 220 / BoxGet Best Price
Product Brochure
Product Details:
| Dosage Form | Injection |
| Folic Acid Strength | Folic Acid (0.7mg) + Methylcobalamin (1500mcg) + Niacinamide (12mg) |
| Pack Size | 1 ml |
| Brand Name | Nurostar C |
| Manufacturer | Mankind Pharma Ltd |
| Composition | Folic Acid (0.7mg) + Methylcobalamin (1500mcg) + Niacinamide (12mg) |
| Treatment | Dietary inadequacies |
Overview: Nurostar C is an injectable formulation that combines mecobalamin (a form of vitamin B12), folic acid, and niacinamide (a form of vitamin B3). This combination is used to support neurological health, treat vitamin deficiencies, and enhance overall metabolic functions.
Indications- Vitamin Deficiencies: Treatment of deficiencies in mecobalamin, folic acid, and niacinamide.
- Peripheral Neuropathy: Often used to promote nerve health and regeneration in conditions like diabetic neuropathy.
- Anemia: Supportive treatment for megaloblastic anemia due to deficiencies in vitamin B12 and folate.
- Overall Wellness: Enhances energy metabolism and supports skin health.
- Mecobalamin: Essential for the production of myelin, which protects nerve fibers, and plays a key role in red blood cell formation and neurological function.
- Folic Acid: Crucial for DNA synthesis, repair, and red blood cell production. It helps prevent neural tube defects during pregnancy.
- Niacinamide: Supports energy production, DNA repair, and healthy skin. It also plays a role in maintaining nerve health.
- Typical Dosage: Dosage may vary based on individual patient needs, often administered as an intramuscular injection. Specific dosing should be determined by a healthcare provider.
- Administration: Usually given once or multiple times a week, depending on the condition being treated.
- Common: Injection site reactions, mild gastrointestinal upset, dizziness, or headache.
- Serious: Allergic reactions, though rare, can occur.
- Hypersensitivity to any component of the formulation.
- Use with caution in patients with a history of allergies to vitamin B12 or other B vitamins.
- Monitor for any allergic reactions during administration.
- Ensure appropriate dosing, particularly in patients with underlying health conditions.
- Store at room temperature, protected from light. Follow specific storage instructions provided by the manufacturer.
- Explain the purpose of the injection and the importance of adhering to the prescribed treatment plan.
- Advise patients to report any unusual symptoms or reactions, especially signs of an allergic response.
Nurostar C injection is a valuable option for managing vitamin deficiencies and supporting nerve health. Proper administration and monitoring are essential to maximize benefits while minimizing risks. Always consult a healthcare provider for personalized advice and treatment recommendations.
Yes! I am InterestedRequest A Callback
Ctx-Gls Cyclophosphamide 500 Mg Injection
Product Price: Rs 85 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Injection Type | Solution |
| Brand | CTX-GLS |
| Form | Injection |
| Composition | Cyclophosphamide 500mg |
| Pack Type | 1 Injection in 1 Vial |
| Brand Name | CTX-GLS 500 |
| Manufactured by | GLS Pharma Ltd |
Ctx-Gls Cyclophosphamide 500 Mg Injection: Effective Treatment for Cancer and Autoimmune Disorders
Overview: Ctx-Gls Cyclophosphamide 500 mg injection is a potent antineoplastic agent used primarily in the treatment of various cancers and certain autoimmune conditions. As an alkylating agent, it works by disrupting the growth of cancer cells, making it a vital component of chemotherapy regimens.
Indications: This injection is indicated for:
- Cancer Treatment: Effective against cancers such as lymphoma, leukemia, and breast cancer.
- Autoimmune Disorders: Used in managing conditions like systemic lupus erythematosus (SLE) and other inflammatory diseases.
Dosage and Administration: Ctx-Gls Cyclophosphamide is typically administered intravenously, with dosages adjusted based on the patient's condition, weight, and overall health. Proper administration should be conducted under the supervision of healthcare professionals.
Mechanism of Action: Cyclophosphamide is a prodrug that becomes activated in the liver, leading to the formation of DNA cross-links. This action inhibits DNA replication and transcription, effectively targeting rapidly dividing cells, such as cancer cells.
Side Effects: Patients receiving Ctx-Gls Cyclophosphamide 500 mg injection may experience side effects including:
- Nausea and vomiting
- Bone marrow suppression, which can lead to increased infection risk
- Hair loss
- Fatigue
More serious side effects, such as bladder toxicity, can occur and require close monitoring.
Precautions: Patients should inform their healthcare provider of any pre-existing medical conditions, particularly kidney or liver issues. Women of childbearing age should discuss potential risks, as cyclophosphamide can affect pregnancy.
Conclusion: Ctx-Gls Cyclophosphamide 500 mg injection is an essential medication in the treatment of cancer and the management of autoimmune disorders. Its effectiveness underscores the importance of careful administration and monitoring by healthcare professionals. For more information about treatment options and personalized care, consult your healthcare provider.
Yes! I am InterestedRequest A Callback
160mg Trastuzumab Emtansine Injection
Product Price: Rs 44,000 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 160mg |
| Physical Form | Concentrate for Injection |
| Drug Type | Standard Trastuzumab |
| Brand | Ujvira |
| Treatment | Breast Cancer |
| Composition | Trastuzumab Emtansine |
| Dose/Strength | 160 mg |
| Pack size | Vial |
| Manufacturer | Zydus ingenia |
Trastuzumab Emtansine Injection (160 mg)
OverviewTrastuzumab emtansine, commonly known as T-DM1, is an antibody-drug conjugate used in the treatment of HER2-positive breast cancer. It combines trastuzumab, which targets the HER2 receptor, with a cytotoxic agent (emtansine) that is delivered directly to the cancer cells.
Indications- HER2-Positive Breast Cancer: Used in patients who have received prior treatment with trastuzumab and chemotherapy, particularly in cases of metastatic disease.
Trastuzumab emtansine targets and binds to the HER2 protein on cancer cells. Once bound, the drug is internalized, and the cytotoxic emtansine is released inside the cell, leading to cell death. This mechanism allows for targeted delivery of chemotherapy to HER2-positive cancer cells, minimizing damage to normal cells.
Dosage and Administration- Typical Dosage: The usual dose is 3.6 mg/kg administered intravenously every three weeks. The dosage may be adjusted based on the patient's weight and response to treatment.
- Administration: Administered by a healthcare professional via intravenous infusion. The first infusion may take longer, and subsequent infusions can be given over a shorter time if tolerated.
- Common Side Effects:
- Fatigue
- Nausea
- Thrombocytopenia (low platelet count)
- Liver enzyme elevation
- Peripheral neuropathy
- Serious Side Effects:
- Cardiotoxicity (heart problems)
- Severe allergic reactions
- Hepatotoxicity (liver damage)
- Hypersensitivity to trastuzumab, emtansine, or any components of the formulation.
- Pregnancy is contraindicated due to potential harm to the fetus.
- Regular monitoring of cardiac function is essential, especially in patients with a history of heart disease.
- Monitor liver function tests periodically during treatment.
- Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light and do not freeze.
- Inform patients about potential side effects, particularly the risk of heart problems and liver toxicity.
- Advise them to report any severe or unusual symptoms, especially signs of an allergic reaction.
Trastuzumab emtansine (160 mg) is an effective treatment for HER2-positive breast cancer, providing targeted therapy that enhances treatment efficacy while reducing systemic exposure. Proper administration and monitoring are crucial for ensuring patient safety and maximizing therapeutic benefits. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion ( Vivitra 440 )
Product Price: Rs 28,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 440 mg |
| Physical Form | Lyophilized Powder |
| Drug Type | Standard Trastuzumab |
| Brand | Vivitra |
| Treatment | Breast Cancer |
| Composition | Trastuzumab 440 mg |
| Pack Size | 1 Injection in 1 vial |
| Manufacturer | Zydus Cadila |
Overview
Vivitra 440 is a lyophilized powder form of Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. Trastuzumab targets the HER2 receptor, which is overexpressed in some cancer cells.
Indications
- Primary Use: Treatment of HER2-positive breast cancer (both early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma.
Mechanism of Action
- Trastuzumab binds to the extracellular domain of the HER2 receptor, inhibiting its signaling pathways that promote cell growth and division. This action slows down tumor growth and may lead to cancer cell death.
Dosage and Administration
- Typical Dosage: The dosing regimen varies based on the specific indication, generally starting with a loading dose followed by maintenance doses (e.g., 8 mg/kg loading dose, then 6 mg/kg every three weeks).
- Administration: Reconstitute the powder with sterile water as per instructions, then administer via intravenous infusion. Infusion rates should be monitored, especially during the first infusion.
Side Effects
Common Side Effects:
- Infusion-related reactions (fever, chills, nausea)
- Fatigue
- Diarrhea
- Headache
- Skin rash
Serious Side Effects:
- Cardiac dysfunction (heart failure)
- Severe allergic reactions (anaphylaxis)
- Pulmonary toxicity
- Hematologic reactions (e.g., neutropenia)
Contraindications
- Hypersensitivity to Trastuzumab or any of its components.
- Patients with a history of serious allergic reactions to the drug.
Warnings and Precautions
- Monitor cardiac function regularly, especially in patients with pre-existing heart conditions.
- Pre-medication may be required to minimize infusion-related reactions.
- Assess for potential pulmonary toxicity.
Storage
- Store the lyophilized powder at 2°C to 8°C (refrigerated). Do not freeze. Once reconstituted, use immediately or store in the refrigerator for a limited time.
Patient Counseling
- Educate patients about potential side effects and the importance of reporting any new symptoms, particularly related to heart function.
- Discuss the need for regular monitoring during treatment and the infusion process.
Conclusion
Vivitra 440 (Trastuzumab) is an essential treatment option for HER2-positive cancers. Proper administration and monitoring can optimize treatment outcomes while minimizing risks. Always consult a healthcare provider for personalized advice and monitoring throughout therapy.
Yes! I am InterestedRequest A Callback
Rozel Denosumab 60mg Injection
Product Price: Rs 11,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 60 mg |
| Dose/Strength | 60 mg |
| Packaging Type | Pre-filled Syringe |
| Brand | Rozel |
| Packaging Size | 1 ml |
| Manufactured By | Intas Pharmaceuticals Ltd |
| Composition | Denosumab 60mg/ml |
| Treatment | Osteoporosis |
Overview
Rozel is a medication used to treat osteoporosis, particularly in postmenopausal women, to increase bone mass and reduce the risk of fractures.
Indications
- Primary Use: Treatment of osteoporosis to slow disease progression and improve bone density.
Mechanism of Action
- Denosumab is a monoclonal antibody that inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), a protein essential for the formation and survival of osteoclasts. By blocking RANKL, it decreases bone resorption, leading to increased bone density.
Dosage and Administration
- Typical Dosage: 60 mg administered as a subcutaneous injection once every six months.
- Administration: Should be given by a healthcare provider or as directed.
Side Effects
-
Common Side Effects:
- Back pain
- Joint pain
- Muscle pain
- Injection site reactions
-
Serious Side Effects:
- Increased risk of infections
- Hypocalcemia (low calcium levels)
- Osteonecrosis of the jaw
- Unusual fractures
Contraindications
- Hypersensitivity to Denosumab or any of its components.
- Patients with low blood calcium levels.
Warnings and Precautions
- Regular monitoring of calcium levels is recommended, especially for those with conditions affecting calcium metabolism.
- Patients should have regular dental check-ups to minimize the risk of osteonecrosis of the jaw.
Storage
- Store in the refrigerator, protected from light. Do not freeze.
Patient Counseling
- Advise patients to maintain adequate calcium and vitamin D intake.
- Educate on recognizing signs of infection and low calcium levels.
Conclusion
Rozel (Denosumab) is an effective treatment for managing osteoporosis. Adherence to the prescribed dosage and regular monitoring can help minimize risks and improve treatment outcomes. Always consult a healthcare provider for personalized advice and monitoring during treatment.
Yes! I am InterestedRequest A Callback
Denosumab Injection (Denoci 120 mg Injection)
Product Price: Rs 18,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 120 mg |
| Dose/Strength | 120 mg |
| Packaging Type | Single-dose Vial |
| Brand | Denoci |
| Packaging Size | 1.7 ml |
| Composition | Denosumab 120mg/1.7ml |
| Manufacturer | Cipla Pvt Ltd |
| Brand Name | Denoci |
| Treatment | Osteoporosis |
Denoci (Denosumab) 120 mg Injection
OverviewDenoci contains denosumab, a monoclonal antibody used primarily to treat conditions associated with bone loss. It is commonly prescribed for osteoporosis and to prevent skeletal-related events in patients with bone metastases.
Indications- Osteoporosis: For the treatment of postmenopausal women at high risk for fractures.
- Bone Metastases: Used in patients with bone metastases from solid tumors to reduce the risk of skeletal-related events, such as fractures and the need for radiation or surgery to bone.
- Giant Cell Tumor of Bone: Approved for patients with unresectable giant cell tumors of bone.
Denosumab works by inhibiting RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand), a protein essential for the formation, function, and survival of osteoclasts (the cells responsible for bone resorption). By blocking RANKL, denosumab decreases bone resorption, leading to increased bone density and strength.
Dosage and Administration- Typical Dosage:
- For osteoporosis: 60 mg subcutaneously once every 6 months.
- For bone metastases: 120 mg subcutaneously every 4 weeks.
- Administration: Denosumab is administered as a subcutaneous injection, usually in the thigh, abdomen, or upper arm. It should be given by a healthcare professional.
- Common Side Effects:
- Hypocalcemia (low calcium levels)
- Skin reactions (rash, eczema)
- Fatigue
- Musculoskeletal pain
- Serious Side Effects:
- Osteonecrosis of the jaw (rare but serious)
- Atypical femoral fractures
- Serious infections (e.g., skin infections)
- Hypersensitivity to denosumab or any components of the formulation.
- Patients with hypocalcemia should not be treated until it is corrected.
- Monitor calcium levels before and during treatment; supplementation may be necessary.
- Assess for signs of osteonecrosis of the jaw, especially in patients with cancer or those undergoing dental procedures.
- Consider screening for infections prior to initiation, as denosumab can increase infection risk.
- Store in the refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. It can be kept at room temperature for a limited time before use.
- Educate patients on the importance of maintaining adequate calcium and vitamin D intake.
- Inform them about potential side effects, particularly signs of low calcium, infection, or jaw problems.
- Encourage patients to report any unusual symptoms or reactions during treatment.
Denoci (denosumab) 120 mg injection is an effective treatment for conditions associated with bone loss, including osteoporosis and bone metastases. Proper administration and monitoring are essential for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Levera Rtu Levetiracetam 500 mg Infusion
Product Price: Rs 80 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Vial Volume | 100 ml |
| Release Type | Immediate |
| Formulation | Immediate |
| Pack Type | Single Bottle |
| Pack Size | 100 ml |
| Composition | Levetiracetam (500mg) |
| Brand Name | Levera RTU |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Treatment | Epilepsy/Seizures |
Overview
Levera is a formulation of levetiracetam, an anticonvulsant medication used to treat seizures in various types of epilepsy. The infusion form is particularly useful for patients who are unable to take oral medications.
Indications
Primary Uses:
- Epilepsy: Used as adjunctive therapy for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and children.
Mechanism of Action
Levetiracetam works by modulating neurotransmitter release through binding to the synaptic vesicle protein SV2A. This action helps stabilize electrical activity in the brain, reducing the frequency and severity of seizures.
Dosage and Administration
Typical Dosage:
- Adults: The usual starting dose is 500 mg administered as an intravenous infusion, with possible adjustments based on clinical response.
- Children: Dosage is typically adjusted based on weight and specific clinical conditions.
Administration:
- Levera is administered as an intravenous infusion, typically over 15 minutes. It should be performed by qualified healthcare professionals.
Side Effects
Common Side Effects:
- Drowsiness
- Fatigue
- Dizziness
- Headache
Serious Side Effects:
- Allergic reactions (rare)
- Mood changes, including depression or aggressive behavior
- Severe skin reactions (very rare)
Contraindications
- Hypersensitivity to levetiracetam or any components of the formulation.
Warnings and Precautions
- Monitor for signs of mood or behavioral changes, especially in patients with a history of psychiatric disorders.
- Gradual withdrawal is recommended to prevent seizure exacerbation in patients who need to discontinue therapy.
Storage
- Store at room temperature (15°C to 30°C). Protect from light and moisture.
Patient Counseling
- Educate patients and caregivers about the purpose of the medication and possible side effects.
- Advise them to report any unusual mood changes or signs of an allergic reaction.
Conclusion
Levera RTU (Levetiracetam 500 mg Infusion) is an effective treatment option for managing seizures in patients with epilepsy, especially when oral administration is not feasible. Proper administration and monitoring are essential for ensuring safety and effectiveness. Always consult a healthcare provider for personalized medical advice and treatment options.
Yes! I am InterestedRequest A Callback
Phytomenadione (Injek 1mg) Injection
Product Price: Rs 10 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 1 mg |
| Pack Size | 0.5 ml |
| Pack Type | Ampoule |
| Drug Composition | Phytomenadione (1mg) |
| Brand Name | Injek |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Hypoprothrombinemia and Vitamin K deficiency |
Overview
Phytomenadione, also known as Vitamin K1, is an injectable form of vitamin K used primarily for the prevention and treatment of vitamin K deficiency and its associated bleeding disorders.
Primary Uses:
- Vitamin K Deficiency: Treatment of conditions related to vitamin K deficiency, which can lead to bleeding disorders.
- Anticoagulant Reversal: Used as an antidote for overdose of anticoagulants such as warfarin, to restore normal clotting function.
- Neonatal Prophylaxis: Administered to newborns to prevent hemorrhagic disease of the newborn.
Phytomenadione plays a crucial role in the synthesis of clotting factors II, VII, IX, and X in the liver. By replenishing vitamin K levels, it helps to restore proper blood coagulation.
Dosage and AdministrationTypical Dosage:
- Adults: Usually 1–10 mg, administered intravenously or subcutaneously, depending on the severity of the deficiency or the indication.
- Newborns: A common prophylactic dose is 0.5–1 mg administered intramuscularly at birth.
Administration:
- Administered by healthcare professionals, preferably via slow intravenous or intramuscular injection.
Common Side Effects:
- Pain at the injection site
- Allergic reactions (e.g., rash, itching)
Serious Side Effects:
- Anaphylactic reactions (rare)
- Thromboembolic events (if used inappropriately)
- Hypersensitivity to Phytomenadione or any components of the formulation.
- Use caution in patients with a history of liver disease or anticoagulant therapy.
- Monitor patients receiving anticoagulant therapy closely for changes in coagulation status.
- Use caution in patients with bleeding disorders other than vitamin K deficiency.
- Store at room temperature (15°C to 30°C), protected from light.
- Educate patients about the importance of vitamin K in blood clotting and its role in their treatment.
- Advise them to report any unusual bleeding or bruising.
Phytomenadione (Injection 1 mg) is an essential treatment for vitamin K deficiency and its complications. Proper administration and monitoring are crucial to ensure effectiveness and safety. Always consult a healthcare provider for personalized medical advice and treatment options.
Yes! I am InterestedRequest A Callback
Folic Acid (0.7mg) and Methylcobalamin and Niacinamide and Vitamin C (Vitcofol C)
Product Price: Rs 115 / BoxGet Best Price
Product Brochure
Product Details:
| Methylcobalamin Strength | 1500 mcg/ml |
| Strength | 1500mcg |
| Pack Size | 2 ml |
| Pack Type | Ampoule |
| Brand Name | Vitcofol C |
| Manufacturer Name | FDC Ltd |
| Composition | Folic Acid (0.7mg) + Methylcobalamin (2500mcg) + Niacinamide (12mg) + Vitamin C (150mg) |
| Treatment | Nutritional deficiencies |
Overview: Vitcofol C is a combination injection that includes folic acid, methylcobalamin (a form of vitamin B12), niacinamide (a form of vitamin B3), and vitamin C. This formulation is used to support various metabolic functions, enhance energy levels, and improve overall health.
Indications- Vitamin Deficiency: Treatment of deficiencies related to folic acid, vitamin B12, niacinamide, and vitamin C.
- Anemia: Supportive treatment for certain types of anemia, particularly megaloblastic anemia due to folate or vitamin B12 deficiency.
- Neuropathy: Often used in cases of peripheral neuropathy to promote nerve health and regeneration.
- Overall Wellness: Enhances immune function, skin health, and energy metabolism.
- Folic Acid (0.7 mg): Essential for DNA synthesis and repair, and crucial for red blood cell formation.
- Methylcobalamin: Supports neurological function, promotes red blood cell production, and is involved in the synthesis of myelin.
- Niacinamide: Aids in energy production, DNA repair, and the maintenance of healthy skin and nerves.
- Vitamin C: Acts as a powerful antioxidant, supports collagen synthesis, enhances iron absorption, and boosts immune function.
- Typical Dosage: Dosage may vary based on individual needs; often administered as a single injection or series of injections based on clinical evaluation.
- Administration: Given intramuscularly or intravenously; healthcare providers will determine the appropriate route and frequency.
- Common: Injection site reactions, mild gastrointestinal disturbances, headache.
- Serious: Allergic reactions, especially in sensitive individuals.
- Hypersensitivity to any component of the formulation.
- Caution in patients with a history of allergic reactions to vitamin B12 or folate.
- Monitor patients for signs of hypersensitivity during administration.
- Ensure appropriate dosing, particularly in patients with renal impairment or specific metabolic disorders.
- Store at room temperature, protected from light. Follow specific manufacturer guidelines for storage conditions.
- Explain the purpose of the injection and the importance of completing the full course of treatment if prescribed.
- Advise patients to report any unusual symptoms or signs of allergic reactions.
Vitcofol C injection is a beneficial combination for addressing vitamin deficiencies and supporting overall health. Proper administration and monitoring are essential for maximizing benefits while minimizing risks. Always consult a healthcare provider for personalized treatment plans and recommendations.
Yes! I am InterestedRequest A Callback
Vitamin C Injection
Product Price: Rs 25 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1.5gm |
| Pack Size | 1 x 5 ml |
| Pack Type | Ampoule |
| Brand Name | Lifestar |
| Manufacturer | Mankind Pharma Ltd |
| Dose/Strength | 1.5 ml |
| Packaging Size | 1.5 ml |
| Composition | Vitamin C 1.5 ml |
| Treatment | Vitamin C deficiency |
Overview: Vitamin C (ascorbic acid) injection is used to treat or prevent vitamin C deficiency and for its potential therapeutic effects in various medical conditions. It is an essential nutrient that plays a key role in collagen synthesis, antioxidant defense, and immune function.
Indications- Vitamin C Deficiency: Treatment of scurvy or prevention in patients unable to obtain adequate dietary intake.
- Adjunct Therapy: May be used in combination with other treatments for conditions like infections, certain cancers, and during recovery from surgery.
- Antioxidant Support: Used in some clinical settings for its antioxidant properties.
Vitamin C acts as a powerful antioxidant, protecting cells from oxidative stress. It also plays a crucial role in collagen synthesis, iron absorption, and the function of various enzymes.
Dosage and Administration- Typical Dosage: Doses can vary based on the indication, but a common adult dose may range from 500 mg to 1000 mg administered intravenously, depending on the clinical context.
- Administration: Given as an intravenous infusion or injection. The rate of administration should be controlled to minimize side effects.
- Common: Mild irritation at the injection site, headache, nausea, diarrhea.
- Serious: Allergic reactions, especially in sensitive individuals; high doses may lead to gastrointestinal upset.
- Hypersensitivity to ascorbic acid or any components of the injection.
- Caution in patients with a history of kidney stones or renal impairment, as high doses can increase the risk of oxalate crystallization.
- Monitor for signs of hypersensitivity during administration.
- High doses may cause gastrointestinal disturbances; adjust the dose accordingly in sensitive patients.
- Store at room temperature, protected from light. Follow specific storage guidelines provided by the manufacturer.
- Explain the purpose of the injection and any potential side effects.
- Advise patients to report any unusual symptoms or signs of allergic reactions.
Vitamin C injection is an important therapeutic option for preventing and treating vitamin C deficiency and providing antioxidant support. Proper administration and monitoring are essential for maximizing benefits and minimizing risks. Always consult a healthcare provider for personalized treatment recommendations.
Yes! I am InterestedRequest A Callback
Mesna 600 mg Injection (Mesolit 600 mg Injection)
Product Price: Rs 300 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 600 mg |
| Packaging Size | 3 ml Injection in 1 Vial |
| Brand | Mesolit |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Ifosfamide-induced hemorrhagic cystitis and cancer chemotherapy |
Mesna Injection (Mesolit 600 mg)
Indications:
Mesna is indicated for the prevention of hemorrhagic cystitis associated with certain chemotherapy agents, particularly ifosfamide and cyclophosphamide. It is used to protect the bladder from the toxic effects of these drugs.
Mechanism of Action:
Mesna acts as a uroprotective agent by binding to the toxic metabolites of ifosfamide and cyclophosphamide in the urine, thereby neutralizing their harmful effects on the bladder mucosa. This helps prevent bladder damage and inflammation.
Dosage and Administration:
- Dosage: The recommended dose of mesna is typically 600 mg administered intravenously. The exact dosing schedule may depend on the specific chemotherapy regimen being used.
- Administration: Administer as an intravenous infusion over 15 minutes. Mesna can also be given orally; if given intravenously, ensure proper hydration.
Contraindications:
- Hypersensitivity to mesna or any component of the formulation.
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of allergic reactions, including rash, itching, or difficulty breathing.
- Hydration: Ensure adequate hydration to help maintain urinary flow and dilute any potential toxic metabolites.
Side Effects:
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Dizziness
Serious side effects can include:
- Severe allergic reactions
- Anaphylaxis
- Flushing
Drug Interactions:
Mesna may interact with other medications, particularly those affecting renal function. Patients should inform their healthcare provider about all medications they are taking.
Storage:
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:
- Advise patients to report any signs of allergic reactions or gastrointestinal symptoms.
- Discuss the importance of staying well-hydrated during treatment.
- Inform patients that mesna is used to protect the bladder from the effects of certain chemotherapy drugs.
Conclusion:
Mesna is an important uroprotective agent that helps prevent bladder toxicity associated with specific chemotherapeutic agents. Ongoing communication with healthcare providers is essential for managing side effects and ensuring optimal therapeutic outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Mesna 200 mg Ijnection (Uromitexan 200mg)
Product Price: Rs 485 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 200mg |
| Packaging Size | 3*2 ml Ampouals |
| Dose/Strength | 200 mg |
| Composition | Mesna 200 mg |
| Brand | Uromitexan |
| Manufacturer | Zydus Cadila |
| Treatment | Ifosfamide-Prompted Hemorrhagic Cystitis |
Overview
Mesna is a medication used primarily as a protective agent during chemotherapy, particularly in patients receiving ifosfamide or cyclophosphamide. It helps to prevent bladder toxicity associated with these drugs.
Indications
- Primary Use: Prevention of hemorrhagic cystitis caused by ifosfamide or cyclophosphamide in cancer treatment.
Mechanism of Action
- Mesna works by binding to and neutralizing toxic metabolites of ifosfamide and cyclophosphamide in the bladder, reducing the risk of bladder damage and bleeding.
Dosage and Administration
- Typical Dosage: The standard dosing schedule involves administering Mesna at a dose of 200 mg, usually given intravenously. It is typically administered before, during, and after chemotherapy.
- Administration: Administer as a slow intravenous injection or infusion.
Side Effects
-
Common Side Effects:
- Nausea
- Vomiting
- Diarrhea
- Rash
-
Serious Side Effects:
- Allergic reactions (e.g., rash, itching)
- Hypotension (low blood pressure)
- Rarely, severe hypersensitivity reactions
Contraindications
- Hypersensitivity to Mesna or any of its components.
Warnings and Precautions
- Use with caution in patients with renal impairment, as dosage adjustments may be necessary.
- Monitor for signs of hypersensitivity reactions.
Storage
- Store at room temperature, away from moisture and light. Protect from freezing.
Patient Counseling
- Inform patients about the purpose of Mesna and the importance of following the prescribed schedule during chemotherapy.
- Advise patients to report any signs of allergic reactions or severe gastrointestinal symptoms.
Conclusion
Mesna (Uromitexan) 200 mg injection is a crucial adjunctive therapy in cancer treatment to protect against bladder toxicity. Adhering to the dosing schedule and monitoring for side effects can help ensure effective management during chemotherapy. Always consult a healthcare provider for personalized advice and monitoring during treatment.
Yes! I am InterestedRequest A Callback
Atosiban Tosiban 6.75mg Injection
Product Price: Rs 145 / StripGet Best Price
Minimum Order Quantity: 10 Strip
Product Brochure
Product Details:
| Brand Name | Tosiban |
| Manufacturer | Zuventus |
| Dose | 6.75mg |
| Packaging Size | 0.9ml |
| Composition | Atosiban Acetate 7.5mg/ml |
| Usage/Application | Untimely Labor |
Yes! I am InterestedRequest A Callback
Ctx-Gls Cyclophosphamide 1000 Mg Injection
Product Price: Rs 120 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1 g |
| Injection Type | Solution |
| Brand | CTX-GLS |
| Form | Injection |
| Composition | Cyclophosphamide 1000mg |
| Pack Type | 1 Injection in 1 Vial |
| Brand Name | CTX-GLS 1000 |
| Manufactured by | GLS Pharma Ltd |
Ctx-Gls Cyclophosphamide 1000 Mg Injection: Effective Cancer Treatment and Autoimmune Disorder Management
Overview: Ctx-Gls Cyclophosphamide 1000 mg injection is a powerful medication used in the treatment of various cancers and certain autoimmune disorders. As an alkylating agent, cyclophosphamide interferes with the growth of cancer cells, making it a key option in chemotherapy protocols.
Indications: This injection is commonly indicated for:
- Cancer Treatment: Effective against lymphoma, leukemia, and breast cancer.
- Autoimmune Disorders: Beneficial in managing conditions like systemic lupus erythematosus (SLE) and vasculitis.
Dosage and Administration: Ctx-Gls Cyclophosphamide is typically administered intravenously, with dosages tailored to the patient's specific needs. Close monitoring is essential to ensure safe and effective treatment.
Mechanism of Action: Cyclophosphamide works by forming DNA cross-links, inhibiting DNA replication and transcription, which is particularly effective in rapidly dividing cancer cells.
Side Effects: Patients receiving Ctx-Gls Cyclophosphamide 1000 mg injection may experience side effects such as nausea, fatigue, and bone marrow suppression. Serious risks, including bladder toxicity, should also be monitored.
Conclusion: Ctx-Gls Cyclophosphamide 1000 mg injection is a critical option in cancer treatment and the management of autoimmune disorders. With its potent efficacy, it is essential for patients to work closely with their healthcare providers for optimal care and monitoring. For more information on cancer treatment options, consult your healthcare professional today.
Yes! I am InterestedRequest A Callback
Arsenox Arsenic Trioxide 1mg Injection
Product Price: Rs 323 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1 mg/mL |
| Packaging Type | Box |
| Packaging Size | 10 ml Vial |
| Country of Origin | Made in India |
| Brand | Arsenox |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usages | Acute Promyelocytic Leukemia (APL) |
Arsenox (Arsenic Trioxide) 1 mg Injection
Indications: Arsenox is primarily indicated for:
- Acute Promyelocytic Leukemia (APL): Treatment of patients with APL who are resistant to or have relapsed after standard therapy.
Mechanism of Action: Arsenic trioxide works by:
- Inducing apoptosis (programmed cell death) in neoplastic cells, particularly in promyelocytic leukemia cells.
- Modulating cellular pathways and promoting differentiation of leukemic cells.
Dosage and Administration:
- Dosage: The typical starting dose is 0.15 to 0.25 mg/kg body weight, administered intravenously. Treatment usually continues until a complete remission is achieved or based on the clinical response.
- Administration: Administered by a healthcare professional experienced in oncology treatments, typically through an intravenous line.
Contraindications:
- Hypersensitivity to arsenic trioxide or any component of the formulation.
- Caution in patients with a history of cardiovascular disease or severe liver dysfunction.
Warnings and Precautions:
- QT Prolongation: Monitor ECG for QT interval prolongation, as arsenic trioxide can lead to cardiac arrhythmias.
- Electrolyte Imbalances: Monitor for imbalances, particularly hypokalemia and hypomagnesemia.
- Differentiation Syndrome: Observe for signs of differentiation syndrome, which can occur in APL patients.
Side Effects:
- Common: Fatigue, nausea, vomiting, headache, and peripheral edema.
- Serious: Cardiac arrhythmias, differentiation syndrome, and severe allergic reactions.
Drug Interactions: Arsenic trioxide may interact with other medications that can affect heart rhythm or those that are metabolized by the liver. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about potential side effects, especially the risk of cardiac issues and electrolyte imbalances.
- Advise patients to report any new symptoms, particularly chest pain, palpitations, or difficulty breathing.
Conclusion: Arsenox (Arsenic Trioxide) 1 mg Injection is a crucial treatment for acute promyelocytic leukemia. Close monitoring for side effects and professional administration are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Adrim 10 mg Doxorubicin Hydrochloride Injection
Product Price: Rs 120 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 10 mg |
| Form | Injection |
| Pack Size | 5 ml |
| Pack Type | Vial |
| Storage Condition | Stable for 2 years when stored at room temperature and protected from light |
| Prescription/Non prescription | Prescription |
| Brand Name | Adrim |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Country of Origin | Made in India |
Doxorubicin Injection (Adrim 10 mg)
Description:
Adrim is a chemotherapy medication containing Doxorubicin, an anthracycline antibiotic that works by inhibiting DNA replication in cancer cells, leading to their death. It is widely used in the treatment of various malignancies.
Indications:
- Breast Cancer: Effective for early-stage and advanced breast cancer, often in combination with other therapies.
- Bladder Cancer: Used for treating transitional cell carcinoma, typically as part of a combination regimen.
- Lymphoma: Administered for both Hodgkin's and non-Hodgkin's lymphoma.
- Leukemia: Included in treatment plans for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
- Sarcomas: Utilized for certain soft tissue sarcomas and bone cancers.
- Other Solid Tumors: Can be effective for various solid tumors, including lung and ovarian cancers.
Dosage and Administration:
- Dosage: Administered intravenously; the specific dose is determined based on the type of cancer and overall treatment plan.
- Administration: Should be given by a qualified healthcare professional in a clinical setting to ensure safety and monitoring.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Hair loss
- Mouth sores
- Decreased blood cell counts, which can increase the risk of infections
Precautions:
- Not suitable for patients with significant heart problems.
- Regular monitoring of heart function and blood counts is essential during treatment.
- Use with caution in pregnant or breastfeeding women.
Yes! I am InterestedRequest A Callback
Metodox 50 mg Doxorubicin Injection
Product Price: Rs 150 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Form | Injection |
| Pack Size | 25 ml |
| Pack Type | Vial |
| Storage Condition | Stable for 2 years when stored at room temperature and protected from light |
| Prescription/Non prescription | Prescription |
| Brand Name | Metodox |
| Manufacturer | Neon Laboratories Ltd |
| Country of Origin | Made in India |
Description:
Metodox is a chemotherapy agent that contains Doxorubicin, an anthracycline antibiotic. It is used to treat various types of cancer by interfering with the DNA replication of cancer cells, ultimately leading to cell death.
Indications:
- Breast Cancer: Effective for both early and advanced stages, often used in combination therapies.
- Bladder Cancer: Used for transitional cell carcinoma, usually as part of combination regimens.
- Lymphoma: Administered for both Hodgkin's and non-Hodgkin's lymphoma.
- Leukemia: Commonly included in treatment protocols for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
- Sarcomas: Utilized in the treatment of soft tissue sarcomas and bone cancers.
- Other Solid Tumors: May be effective against various solid tumors, including lung and ovarian cancers.
Dosage and Administration:
- Dosage: Administered intravenously; the specific dose is determined based on the type of cancer and overall treatment plan.
- Administration: Should be administered by a qualified healthcare professional in a clinical setting for monitoring.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Hair loss
- Mouth sores
- Low blood cell counts, increasing infection risk
Precautions:
- Not suitable for patients with significant heart issues.
- Regular monitoring of heart function and blood counts is essential during treatment.
- Caution is advised for use in pregnant or breastfeeding women.
Yes! I am InterestedRequest A Callback
Metodox 10 mg Doxorubicin Injection
Product Price: Rs 45 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 10 mg |
| Form | Injection |
| Pack Size | 5 ml |
| Pack Type | Vial |
| Storage Condition | Stable for 2 years when stored at room temperature and protected from light |
| Brand Name | Metodox |
| Prescription/Non prescription | Prescription |
| Manufacturer | Neon Laboratories Ltd |
| Country of Origin | Made in India |
Doxorubicin Injection (Metodox 10 mg)
Description:
Metodox is a chemotherapy medication used to treat a variety of cancers. It contains Doxorubicin, an anthracycline that interferes with DNA replication in cancer cells, leading to cell death.
Indications:
- Breast Cancer: Used in both early and advanced stages.
- Bladder Cancer: Effective for transitional cell carcinoma, often in combination therapy.
- Lymphoma: Administered for Hodgkin's and non-Hodgkin's lymphoma.
- Leukemia: Included in treatment regimens for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
- Sarcomas: Utilized for certain soft tissue sarcomas and bone cancers.
- Other Cancers: May also be effective for solid tumors, such as lung and ovarian cancers.
Dosage and Administration:
- Dosage: Administered intravenously; the specific dosage is determined by the type of cancer and treatment protocol.
- Administration: Should be given by a healthcare professional in a clinical setting to ensure proper monitoring.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Hair loss
- Mouth sores
- Decreased blood cell counts, increasing the risk of infections
Precautions:
- Not suitable for patients with certain heart conditions.
- Regular monitoring of heart function and blood counts is necessary during treatment.
- Caution is advised for pregnant or breastfeeding women.
Yes! I am InterestedRequest A Callback
Adrim 50 mg Doxorubicin Hydrochloride Injection
Product Price: Rs 650 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Form | Injection |
| Pack Size | 25 ml |
| Pack Type | Vial |
| Storage Condition | Stable for 2 years when stored at room temperature and protected from light |
| Prescription/Non prescription | Prescription |
| Brand Name | Adrim |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Country of Origin | Made in India |
Description:
Adrim is a potent chemotherapy agent containing Doxorubicin Hydrochloride, an anthracycline antibiotic. It works by disrupting DNA synthesis in cancer cells, thereby inhibiting their growth and inducing cell death.
Indications:
- Breast Cancer: Used for both early and metastatic breast cancer, often as part of combination therapy.
- Bladder Cancer: Effective for treating transitional cell carcinoma, typically in combination with other drugs.
- Lymphoma: Administered for both Hodgkin's and non-Hodgkin's lymphoma.
- Leukemia: Frequently part of treatment protocols for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
- Sarcomas: Used in the management of soft tissue sarcomas and certain types of bone cancers.
- Other Solid Tumors: Can be effective against a variety of solid tumors, including those of the lung and ovary.
Dosage and Administration:
- Dosage: Given intravenously; specific doses depend on the cancer type and treatment regimen.
- Administration: Must be administered by a healthcare professional in a clinical setting for proper monitoring.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Hair loss
- Mouth sores
- Lowered blood cell counts, which may increase infection risk
Precautions:
- Not recommended for patients with certain heart conditions.
- Regular monitoring of cardiac function and blood counts is crucial during treatment.
- Caution is necessary for pregnant or breastfeeding women.
Yes! I am InterestedRequest A Callback
Doxotero 50 mg Doxorubicin Hydrochloride Injection
Product Price: Rs 200 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Form | Injection |
| Pack Size | 25 ml |
| Pack Type | Vial |
| Storage Condition | Stable for 2 years when stored at room temperature and protected from light |
| Prescription/Non prescription | Prescription |
| Brand Name | Doxotero |
| Manufacturer | Hetero Drugs Ltd |
| Usages | Breast Cancer, Lung Cancer, Malignant lymphomas, and certain types of Leukemia |
Doxorubicin Hydrochloride Injection (Doxotero 50 mg)
Description:
Doxotero is an effective chemotherapy agent used to treat various types of cancer, including breast cancer, bladder cancer, and lymphoma. It contains Doxorubicin, an anthracycline that works by inhibiting DNA replication, leading to cancer cell death.
Indications:
- Breast Cancer: For treatment of early and advanced hormone receptor-positive and negative breast cancer.
- Lymphoma: Used in combination therapy for Hodgkin's and non-Hodgkin's lymphoma.
- Other Cancers: Effective in treating various solid tumors, including lung and ovarian cancers.
Dosage and Administration:
- Dosage: Administered intravenously, the specific dose depends on the type of cancer and treatment regimen.
- Administration: Should be given under the supervision of a healthcare professional; proper handling and monitoring are essential due to potential side effects.
Common Side Effects:
- Nausea and vomiting
- Hair loss
- Fatigue
- Mouth sores
- Low blood cell counts, increasing infection risk
Precautions:
- Not suitable for patients with certain heart conditions.
- Monitor heart function and blood counts during treatment.
- Use caution in pregnant or breastfeeding women.
Yes! I am InterestedRequest A Callback
View More